arrow
L

Lau, Harold

3395 hospital drive nw
H指数:0
被引数:13

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of Life of Stereotactic vs. Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results from the XXXXXX trial

立体定向放疗与低分割放疗治疗不可手术的Ⅰ期非小细胞肺癌的生活质量比较:XXXXXX试验的结果

2025-11-210
OAAI
Baseline Characteristics of Individuals with Metastatic Cancer Enrolled in the Alberta Cancer Exercise Study and 12-Week Findings for Symptom-Related and Physical Fitness Measures

入组阿尔伯塔癌症运动研究的转移性癌症患者基线特征及12周症状相关和身体机能指标的观察结果

2025-10-070
OAAI
Role of Qualified Exercise Professionals in Medical Clearance for Exercise: Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

合格运动专业人员在外科运动许可中的作用:阿尔伯塔癌症运动混合效果-实施研究

2025-09-010
OA
Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
2023-10-014
OAAI
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126

接受前列腺放疗的男性的身体成分和死亡率: NRG/RTOG 9406和NRG/RTOG 0126的汇总分析

CANCER
IF5.1
2022-12-295
PRE
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126
2022-01-0110
OAAI
Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer
2015-11-010
PREAI
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial
CANCER
IF5.1
2015-04-0250
OAAI